MEI Pharma: Letter to holders highlights value of Infinity Pharma transaction

MEI Pharma (MEIP) issued the following letter to shareholders reiterating the Board of Directors recommendation to vote FOR the pending transaction with Infinity Pharmaceuticals (INFI) in connection with the Company’s special meeting on July 14…”The special meeting of shareholders at which you will have the opportunity to vote FOR our pending transaction with Infinity Pharmaceuticals, Inc. is fast approaching. Our transaction with Infinity provides our shareholders the opportunity to benefit from the upside potential of a combined company that is well capitalized and positioned to advance a diversified pipeline. To capture that opportunity, we encourage you to vote FOR the proposals related to the transaction in connection with the special meeting of shareholders on July 14″